Esophageal luminal temperature monitoring using a multi-sensor probe lowers the risk of esophageal injury in cryo and radiofrequency catheter ablation for atrial fibrillation.
Atrial fibrillation ablation
Esophageal lesions
Luminal esophageal temperature monitoring
Journal
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
11
12
2022
accepted:
22
01
2023
medline:
23
10
2023
pubmed:
7
2
2023
entrez:
6
2
2023
Statut:
ppublish
Résumé
Esophageal luminal temperature monitoring is a commonly used strategy to reduce esophageal thermal injury in catheter ablation for atrial fibrillation (AFib). We sought to compare the incidence of endoscopically detected esophageal lesions (EDEL) between two commonly used esophageal luminal temperature probes. Consecutive patients undergoing ablation with esophageal luminal temperature monitoring and upper endoscopy within 24 h after ablation were included. Four hundred forty-five patients (64 ± 10 years, 44% female) were included. Esophageal temperature monitoring was done with a single-sensor probe in 213 (48%) and multi-sensor probe in 232 (52%). Cryoballoon (CB) ablation was performed in 118 (27%) and radiofrequency (RF) ablation in 327 (73%) of patients. EDEL was present in 94 (22.9%) of which 85 were mild, 8 were moderate, and 1 was severe, and none progressed to atrial-esophageal fistula. The use of the multi-sensor probe during CB ablation was associated with a reduction in EDEL compared to single sensor (6.8% vs 24.3%; P = 0.016). Similarly, in the RF ablation group, EDEL was present in 19.5% of the multi-sensor group vs 32.8% in the single-sensor group (P = 0.001). Logistic regression showed that multi-sensor probe use was associated with reduction in EDEL with an odds ratio of 0.23 in CB ablation (P = 0.024) and 0.44 for RF ablation (P = 0.001). Esophageal luminal temperature monitoring during AFib ablation using a multi-sensor probe was associated with a significant reduction in EDEL compared to a single-sensor probe.
Sections du résumé
BACKGROUND
BACKGROUND
Esophageal luminal temperature monitoring is a commonly used strategy to reduce esophageal thermal injury in catheter ablation for atrial fibrillation (AFib).
OBJECTIVES
OBJECTIVE
We sought to compare the incidence of endoscopically detected esophageal lesions (EDEL) between two commonly used esophageal luminal temperature probes.
METHODS
METHODS
Consecutive patients undergoing ablation with esophageal luminal temperature monitoring and upper endoscopy within 24 h after ablation were included.
RESULTS
RESULTS
Four hundred forty-five patients (64 ± 10 years, 44% female) were included. Esophageal temperature monitoring was done with a single-sensor probe in 213 (48%) and multi-sensor probe in 232 (52%). Cryoballoon (CB) ablation was performed in 118 (27%) and radiofrequency (RF) ablation in 327 (73%) of patients. EDEL was present in 94 (22.9%) of which 85 were mild, 8 were moderate, and 1 was severe, and none progressed to atrial-esophageal fistula. The use of the multi-sensor probe during CB ablation was associated with a reduction in EDEL compared to single sensor (6.8% vs 24.3%; P = 0.016). Similarly, in the RF ablation group, EDEL was present in 19.5% of the multi-sensor group vs 32.8% in the single-sensor group (P = 0.001). Logistic regression showed that multi-sensor probe use was associated with reduction in EDEL with an odds ratio of 0.23 in CB ablation (P = 0.024) and 0.44 for RF ablation (P = 0.001).
CONCLUSIONS
CONCLUSIONS
Esophageal luminal temperature monitoring during AFib ablation using a multi-sensor probe was associated with a significant reduction in EDEL compared to a single-sensor probe.
Identifiants
pubmed: 36745324
doi: 10.1007/s10840-023-01492-1
pii: 10.1007/s10840-023-01492-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1827-1835Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA, J Am Med Assoc. 2019;321:1261–74. https://doi.org/10.1001/jama.2019.0693 .
doi: 10.1001/jama.2019.0693
Piorkowski C, Hindricks G, Schreiber D, et al. Electroanatomic reconstruction of the left atrium, pulmonary veins, and esophagus compared with the “true anatomy” on multislice computed tomography in patients undergoing catheter ablation of atrial fibrillation. Heart Rhythm. 2006;3:317–27. S1547–5271(05)02419–7 [pii].
Cappato R, Calkins H, Chen SA, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111:1100–5. 01.CIR.0000157153.30978.67 [pii].
Mortsell D, Arbelo E, Dagres N, et al. Cryoballoon vs. radiofrequency ablation for atrial fibrillation: a study of outcome and safety based on the ESC-EHRA atrial fibrillation ablation long-term registry and the Swedish Catheter Ablation Registry. Europace. 2019;21(4):581–9. https://doi.org/10.1093/europace/euy239 .
Stollberger C, Pulgram T, Finsterer J. Neurological consequences of atrioesophageal fistula after radiofrequency ablation in atrial fibrillation. Arch Neurol. 2009;66:884–7. https://doi.org/10.1001/archneurol.2009.105 .
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. J Arrhythm. 2017;33(5):369–409.
doi: 10.1016/j.joa.2017.08.001
pubmed: 29021841
pmcid: 5634725
Vassallo F, Cunha C, Serpa E, et al. Comparison of high-power short-duration (HPSD) ablation of atrial fibrillation using a contact force-sensing catheter and conventional technique: initial results J Cardiovasc Electrophysiol. 2019;30(10):1877–83. https://doi.org/10.1111/jce.14110 .
Parikh V, Swarup V, Hantla J, et al. Feasibility, safety, and efficacy of a novel preshaped nitinol esophageal deviator to successfully deflect the esophagus and ablate left atrium without esophageal temperature rise during atrial fibrillation ablation: the DEFLECT GUT study. Heart Rhythm. 2018;15(9):1321–7.
Leung LW, Gallagher MM, Santangeli P, et al. Esophageal cooling for protection during left atrial ablation: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2020;59(2):347–55. https://doi.org/10.1007/s10840-019-00661-5 .
Kapur S, Barbhaiya C, Deneke T, Michaud GF. Esophageal injury and atrioesophageal fistula caused by ablation for atrial fibrillation. Circulation. 2017;136(13):1247–55.
doi: 10.1161/CIRCULATIONAHA.117.025827
pubmed: 28947480
Khairy P, Dubuc M. Transcatheter cryoablation part I: preclinical experience. Pacing Clin Electrophysiol. 2008;31(1):112–20.
doi: 10.1111/j.1540-8159.2007.00934.x
pubmed: 18181919
John RM, Kapur S, Ellenbogen KA, Koneru JN. Atrioesophageal fistula formation with cryoballoon ablation is most commonly related to the left inferior pulmonary vein. Heart Rhythm. 2017;14(2):184–9.
doi: 10.1016/j.hrthm.2016.10.018
pubmed: 27769853
Singh SM, d’Avila A, Doshi SK, Brugge WR, Bedford RA, Mela T, et al. Esophageal injury and temperature monitoring during atrial fibrillation ablation. Circ Arrhythm Electrophysiol. 2008;1(3):162–8.
doi: 10.1161/CIRCEP.108.789552
pubmed: 19808410
Nakagawa H, Seres KA, Jackman WM. Limitations of esophageal temperature-monitoring to prevent esophageal injury during atrial fibrillation ablation. Circ Arrhythm Electrophysiol. 2008;1(3):150–2.
doi: 10.1161/CIRCEP.108.805366
pubmed: 19808408
Carroll BJ, Contreras-Valdes FM, Heist EK, et al. Multi-sensor esophageal temperature probe used during radiofrequency ablation for atrial fibrillation is associated with increased intraluminal temperature detection and increased risk of esophageal injury compared to single-sensor probe. J Cardiovasc Electrophysiol. 2013;24:958–64. https://doi.org/10.1111/jce.12180 .
Leshem E, Zilberman I, Tschabrunn CM, Barkagan M, Contreras-Valdes FM, Govari A, et al. High-power and short-duration ablation for pulmonary vein isolation: biophysical characterization. JACC Clin Electrophysiol. 2018;4(4):467–79.
doi: 10.1016/j.jacep.2017.11.018
pubmed: 30067486
Kottmaier M, Popa M, Bourier F, Reents T, Cifuentes J, Semmler V, et al. Safety and outcome of very high-power short-duration ablation using 70 W for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. Europace. 2020;22(3):388–93.
doi: 10.1093/europace/euz342
pubmed: 31872249
Tschabrunn CM, Silverstein J, Berzin T, et al. Comparison between single- and multi-sensor oesophageal temperature probes during atrial fibrillation ablation: thermodynamic characteristics. Europace. 2015;17:891–7. https://doi.org/10.1093/europace/euu356 .
Sarairah SY, Woodbury B, Methachittiphan N, Tregoning DM, Sridhar AR, Akoum N. Esophageal thermal injury following cryoballoon ablation for atrial fibrillation. JACC Clin Electrophysiol. 2020;6(3):262–8.
doi: 10.1016/j.jacep.2019.10.014
pubmed: 32192675
Halbfass P, Pavlov B, Muller P, Nentwich K, Sonne K, Barth S, et al. Progression from esophageal thermal asymptomatic lesion to perforation complicating atrial fibrillation ablation: a single-center registry. Circ Arrhythm Electrophysiol. 2017;10(8):10.1161/CIRCEP.117.005233. https://doi.org/10.1161/CIRCEP.117.005233 .
Barbhaiya CR, Kumar S, Guo Y, Zhong J, John RM, Tedrow UB, et al. Global survey of esophageal injury in atrial fibrillation ablation: characteristics and outcomes of esophageal perforation and fistula. JACC: Clin Electrophysiol. 2016;2(2):143–50.
Rillig A, Meyerfeldt U, Birkemeyer R, Wiest S, Sauer BM, Staritz M, et al. Oesophageal temperature monitoring and incidence of oesophageal lesions after pulmonary vein isolation using a remote robotic navigation system. Europace. 2010;12(5):655–61.
doi: 10.1093/europace/euq061
pubmed: 20233761
Yamasaki H, Tada H, Sekiguchi Y, Igarashi M, Arimoto T, Machino T, et al. Prevalence and characteristics of asymptomatic excessive transmural injury after radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm. 2011;8(6):826–32.
doi: 10.1016/j.hrthm.2011.01.045
pubmed: 21315839
Di Biase L, Saenz LC, Burkhardt DJ, Vacca M, Elayi CS, Barrett CD, et al. Esophageal capsule endoscopy after radiofrequency catheter ablation for atrial fibrillation: documented higher risk of luminal esophageal damage with general anesthesia as compared with conscious sedation. Circ Arrhythm Electrophysiol. 2009;2(2):108–12.
doi: 10.1161/CIRCEP.108.815266
pubmed: 19808454
Martinek M, Hassanein S, Bencsik G, Aichinger J, Schoefl R, Bachl A, et al. Acute development of gastroesophageal reflux after radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm. 2009;6(10):1457–62.
doi: 10.1016/j.hrthm.2009.06.022
pubmed: 19716773